http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101322478-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-618 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101322478-B1 |
| titleOfInvention | Abalone gut gastrointestinal digestive hydrolyzate having inhibitory effect on MPM and pharmaceutical composition containing the same as an active ingredient |
| abstract | The present invention is abalone intestine gastro-intestinal digests (AIGID) and MMP-2, MMP- containing it as an active ingredient having an inhibitory effect on MMP (Matrix metalloproteinases: hereinafter, 'MMP') activity 9 A pharmaceutical composition for inhibiting activity, which has a beneficial effect of preventing or treating diseases associated with MMP activity, such as cancer, neurodegenerative, cardiovascular and various inflammatory diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102385070-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220001541-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101809800-B1 |
| priorityDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 252.